Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000899243-20-031922

Options or other derivatives

  • Director acquired 27,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dallas Jayson Donald Alexander Director 2020-11-19 Grant or award · Stock Option (right to buy) +18,000 18,000 D: show line 1 in the form
Dallas Jayson Donald Alexander Director 2020-11-19 Grant or award · Stock Option (right to buy) +9,000 9,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…